Invest in IPO Lupin Ltd - Company Information, Share/Stock Price, Market Summary, Arihant Capital

Lupin Ltd

  • BSE Code : 500257
  • NSE Symbol : LUPIN
  • ISIN : INE326A01037
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 2,068.50 -36.90(-1.75%)

Open Price ()

2,107.70

Prev. Close ()

2,105.40

Volume (No’s)

202,126

Market Cap ()

96,125.20

Low Price ()

2,053.20

High Price ()

2,115.90

 

Corporate Announcement

28-Apr-2025 Lupin Limited - ESOP/ESOS/ESPS
24-Apr-2025 Lupin Limited - Press Release
23-Apr-2025 Lupin Limited - Press Release
17-Apr-2025 Lupin Limited - Other General Purpose
16-Apr-2025 Lupin Limited - News Verification

Stock Summary

Market Cap(₹Cr.)

96,230.21

P/E (TTM)

30.76

Book value ()

481.38

Div Yield (%)

0.38

EPS (TTM)

68.52

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

2,144.57

Resistance 2

2,183.73

Support 1

2,040.67

Support 2

1,975.93

Moving Average

30 Days

2,019.29

50 Days

2,006.81

100 Days

2,083.06

200 Days

2,087.01

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Lupin Ltd 96,230.21 30.76 3.58 3565.79 0.38 68.52
Sun Pharmaceutical Indust.. 441,909.51 140.27 16.41 5834.35 0.73 13.13
Divis Laboratories Ltd 160,035.08 77.2 6.75 2512 0.5 78.09
Cipla Ltd 125,536.01 26.97 4.31 5917.87 0.84 57.63
Torrent Pharmaceuticals L.. 112,888.48 61.89 12.89 2980.66 0.84 53.9

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 99743261 21.85
Total Institutions 116005612 25.41
Total Govt Holding 36052 0.01
Total Non Promoter Corporate Holding 1347379 0.30
Total Promoters 214207514 46.92
Total Public & others 25225227 5.53
Total 456565045 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.

Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited. In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In the year 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.

They commenced supply of Cephalosporin bulk actives to their alliance pa...

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew